Compare RLTY & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RLTY | ELMD |
|---|---|---|
| Founded | 2022 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.5M | 226.4M |
| IPO Year | 2021 | 2010 |
| Metric | RLTY | ELMD |
|---|---|---|
| Price | $14.92 | $27.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $48.50 |
| AVG Volume (30 Days) | ★ 76.7K | 35.0K |
| Earning Date | 01-01-0001 | 11-10-2026 |
| Dividend Yield | ★ 9.35% | N/A |
| EPS Growth | N/A | ★ 52.94 |
| EPS | N/A | ★ 1.30 |
| Revenue | N/A | ★ $54,716,000.00 |
| Revenue This Year | N/A | $12.71 |
| Revenue Next Year | N/A | $10.70 |
| P/E Ratio | ★ N/A | $20.78 |
| Revenue Growth | N/A | ★ 13.83 |
| 52 Week Low | $13.34 | $23.01 |
| 52 Week High | $16.41 | $47.40 |
| Indicator | RLTY | ELMD |
|---|---|---|
| Relative Strength Index (RSI) | 65.45 | 45.78 |
| Support Level | $14.04 | $25.64 |
| Resistance Level | $15.92 | $28.48 |
| Average True Range (ATR) | 0.25 | 0.95 |
| MACD | 0.12 | 0.11 |
| Stochastic Oscillator | 92.86 | 41.18 |
Cohen & Steers Real Estate Opportunities and Income Fund is a non-diversified, closed-end management statutory trust. Its primary investment objective is high current income. Its secondary investment objective is capital appreciation. The fund invests the majority of its managed assets in real estate-related investments and preferred and other income securities.
Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S. to the homecare and hospital markets. Its product includes the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The company operates in a single segment: developing, manufacturing, and marketing medical equipment. The company generates revenue from Homecare, Hospital, Homecare Distributor, and Other.